Welcome to: Beijing Dongfang Baitai Biotechnology Co., Ltd
CN
News trends
Position:
Homepage
/
/
/
Dongfang Baitai was approved to set up a postdoctoral research workstation
Check category

Dongfang Baitai was approved to set up a postdoctoral research workstation

  • Categories:Company News
  • Author:
  • Origin:Dongfang Baitai
  • Time of issue:2022-05-23
  • Views:687

(Summary description)Recently, with the approval of the Ministry of Human Resources and Social Security and the National Postdoctoral Management Committee, Beijing Dongfang Baitai Biotechnology Co., Ltd. successfully established a postdoctoral research workstation. It is used to further cultivate and introduce high-level scientific and technological talents, to help promote the company's intensive R&D projects, and also marks a new step in the company's scientific research strength.

Dongfang Baitai was approved to set up a postdoctoral research workstation

(Summary description)Recently, with the approval of the Ministry of Human Resources and Social Security and the National Postdoctoral Management Committee, Beijing Dongfang Baitai Biotechnology Co., Ltd. successfully established a postdoctoral research workstation. It is used to further cultivate and introduce high-level scientific and technological talents, to help promote the company's intensive R&D projects, and also marks a new step in the company's scientific research strength.

  • Categories:Company News
  • Author:
  • Origin:Dongfang Baitai
  • Time of issue:2022-05-23
  • Views:687
Information

Recently, with the approval of the Ministry of Human Resources and Social Security and the National Postdoctoral Management Committee, Beijing Dongfang Baitai Biotechnology Co., Ltd. successfully established a postdoctoral research workstation. It is used to further cultivate and introduce high-level scientific and technological talents, to help promote the company's intensive R&D projects, and also marks a new step in the company's scientific research strength.

 

 

What is a postdoctoral research workstation?

Postdoctoral research workstation refers to an organization that can recruit and train postdoctoral researchers in enterprises, research and production oriented institutions and special regional institutions upon approval. The purpose of establishing post doctoral research workstation is to attract, train and use high-level young talents, especially innovative talents. At the same time, a flexible mechanism conducive to the flow of talents should be established to promote scientific research, technological development, achievements transformation and other scientific and technological research and development activities. It has built a bridge for China's high-tech talents and enterprises, and is a new way to combine production, learning and research.

 

The significance of postdoctoral research workstation

The establishment of the postdoctoral research workstation is conducive to giving play to the role of the postdoctoral system in selecting and cultivating excellent scientific research talents. It can widely attract doctors with high professional and technical level and strong scientific research practice ability to join the enterprise's scientific research team. We will encourage outstanding postdoctoral researchers with development potential and innovation ability to conduct innovative research. It is conducive to the in-depth development of R&D projects. We will further accelerate the transformation of scientific and technological achievements into real productive forces. It is of great significance to promote independent innovation and enhance the core competitiveness of enterprises. It is forward-looking, innovative and exemplary. At the same time, it marks that the scientific research work of the enterprise has entered a new stage and the innovation level has been further improved.

 

 

Dongfang Baitai Postdoctoral Scientific Research Workstation

Beijing Dongfang Baitai Biotechnology Co., Ltd. is located in Beijing Economic and Technological Development Zone. It covers an area of nearly 60000 square meters. It is a high-tech enterprise focusing on the R&D and industrialization of new products of major disease treatment and preventive biological medicine. It fully conforms to the national requirements for post doctoral research workstation. Moreover, the company urgently needs to set up a station to attract more high-end talents to participate in antibody drug research and development, so as to ease the problem of difficult drug use for Chinese people.

 

 

1、 Personnel team:

Dongfang Baitai has always paid attention to the cultivation of innovative scientific and technological talents. After years of development, we now have a core R&D team composed of senior experts with rich industry experience and complete professional capabilities. The total number of employees is more than 100, including 14 doctors and 47 masters, accounting for more than half. More than 80% of them are R&D personnel. It has laid a solid foundation for the sustainable innovative development of the company.

2、 Honors and qualifications:

The company has been recognized and supported by the state and governments at all levels for many times. It is recognized by the Ministry of Science and Technology of the People's Republic of China as the "international scientific and technological cooperation base for frontier technologies of national new antibody and therapeutic protein drugs". It has the first batch of antibody engineering laboratories of Beijing Municipal Development and Reform Commission, Beijing Engineering Research Center for Antibody Drugs, Beijing Genetic Engineering Antibody Drug Engineering Technology Research Center, and Beijing International Cooperation Base for New Antibodies and Therapeutic Proteins. It is also a "G20 backup" enterprise. Recently, "Dongfang Baitai Academician Expert Workstation" was awarded by Beijing Association for Science and Technology, which has a dominant position in antibody drug research and development.

3、 National projects undertaken:

Dongfang Baitai has successively undertaken a number of national "863" projects, provincial and ministerial key science and technology projects and other major government research projects during the 12th and 13th Five Year Plan. It includes 7 national major new drug development projects, 3 international cooperation projects, and more than 10 R&D projects of Beijing Municipal Science and Technology Commission, Development and Reform Commission and Economic and Information Commission. After the Ebola and Zika outbreaks, Dongfang Baitai has successively undertaken the research and development of related antibody drugs in the working mechanism of joint prevention and control of major infectious diseases in China, which not only fully affirmed the technical strength of Dongfang Baitai, but also showed its contribution to the development of the biomedical industry.

4、 Research and development of projects carried out:

The R&D projects that the company has carried out: the R&D pipeline layout for more than 20 major diseases such as anti-tumor, diabetes and autoimmune diseases has obtained 5 clinical approval documents for new drugs. The indications of the products under research cover many high incidence diseases such as malignant tumors, rheumatoid arthritis, hyperlipidemia, diabetes, etc; The product categories include all human monoclonal antibody, humanized monoclonal antibody, bispecific antibody, antibody fusion protein, antibody coupling drug, therapeutic vaccine, etc.

The company pays great attention to the research and development of new technology products. It has dozens of core invention patents. The drug JY09 for type II diabetes has won patents in China, the United States, Europe, Japan, South Korea, Eurasia and other countries and regions, and the patents for tumor immunotherapy have entered the international PCT stage. The production of any product will be a "blockbuster" type drug of biomedicine.

5、 R&D platform:

Dongfang Baitai has built an industrial technology platform featuring original antibody drugs and new vaccines at the world's advanced level and integrated research and production. It truly realizes the penetration of antibody R&D technology and the whole production process. include:

1) Large capacity antibody library construction platform

2) High throughput innovative antibody screening platform

3) Antibody drug (ADC) coupling platform

4) , Double specific antibody construction platform

5) Therapeutic vaccine development platform

6) High expression mammalian cell line screening

7) Process optimization platform

8) Pilot production platform

9) Quality control platform

10) Pharmacodynamics and toxicology platform

11) Large scale industrialization platform.

6、 Pilot production line:

The existing pilot plant production line covers an area of about 800 square meters. It is a pilot production line conforming to
GMP standards. It consists of upstream cell culture production line and downstream protein purification production line. This cell culture pilot production line focuses on the development of suspended mammalian cell culture process and amplification. It is widely used in pilot production of antibody proteins and clinical sample production services.

7、 Production line:

At present, the company is building a new antibody R&D and production base. It has one 3000L mammalian cell large-scale batch culture and purification production line and one bacterial/yeast production line and other R&D industrial facilities.


Future planning of workstation

Dongfang Baitai attaches great importance to the construction and management of postdoctoral research stations. We adhere to the development path of "combining production, teaching and research". In the next step, the company will actively integrate internal resources, divide responsibilities, and form an organization and management system with reasonable operation and efficient coordination. According to the enterprise's R&D strategy, scientific research tasks, and the actual needs of personnel training and use, the medium and long-term plans for the development of postdoctoral workstations are carefully formulated. According to the characteristics of post doctoral work, establish and improve the daily management system of post doctoral work, promote the standardization of post doctoral work, and provide the conditions and places required by the research for incoming doctors.

Dongfang Baitai Postdoctoral Research Workstation cooperates with domestic famous universities and research institutes' postdoctoral mobile stations. We will jointly cultivate a group of high-level professionals. Now we are open to the public to recruit 2018 Dongfang Baitai postdoctoral researchers. We sincerely welcome relevant professional doctoral graduates to join us!
We are willing to seize the historical opportunity of the development of bio pharmaceutical industrialization, focus on the innovation and development of monoclonal antibody drug technology, and make our own contribution to the benefit of advanced antibody drug research achievements to patients in China and the world!

Scan the QR code to read on your phone

推荐新闻

Follow us

1

Follow the official WeChat official account

Or search "Oriental Baitai"

More exciting waiting for you!

Address: No. 2, Rongjing East Street, Beijing Economic and Technological Development Zone
Tel.: 010-51571019
Email: ebt@east-bt.com

Copyright 2021 Beijing Dongfang Baitai Biotechnology Co., Ltd    SEO    京ICP备********号 

Beijing Dongfang Baitai Biotechnology Co., Ltd

Online customer service
Customer service hotline
010-51571019 010-51571019
Service time:
8:30 - 17:30
Customer service group:
在线客服